{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:58:54Z","timestamp":1790078334750,"version":"4.0.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:00:00Z","timestamp":1599264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:00:00Z","timestamp":1599264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The Australian paralysis tick, <jats:italic>Ixodes holocyclus,<\/jats:italic> causes tick paralysis in dogs and cats in the eastern coastal regions of Australia. Prevention is the best option to protect dogs against this potentially fatal disease and sarolaner provides rapid and sustained efficacy against <jats:italic>I. holocyclus<\/jats:italic>. In this laboratory study, the efficacy of two combination endectocides containing sarolaner\u2009+\u2009moxidectin\u2009+\u2009pyrantel (Simparica Trio\u2122)\u00a0and afoxolaner\u2009+\u2009milbemycin (NexGard Spectra<jats:sup>\u00ae<\/jats:sup>) was evaluated against an artificial infestation of <jats:italic>I. holocyclus<\/jats:italic>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Twenty-four (<jats:italic>n<\/jats:italic> =24) foxhounds were randomly allocated to three treatment groups and artificially infested with 30 adult female viable ticks on Days \u2212\u20091, 7, 14, 21, 28 and 35. On Day 0, dogs in each treatment group were treated with either Drontal<jats:sup>\u00ae<\/jats:sup> (control group), Simparica Trio\u2122 at the label dose to provide minimum doses of sarolaner (1.2 mg\/kg), moxidectin (24 \u00b5g\/kg) and pyrantel (5 mg\/kg) or NexGard Spectra<jats:sup>\u00ae<\/jats:sup> to provide minimum doses of afoxolaner (2.5 mg\/kg) and milbemycin (0.5 mg\/kg). Live tick counts were performed at 48 and 72 hours after treatment and after each re-infestation on Days 7, 14, 21, 28 and 35. Efficacy was determined at each time point relative to counts for control dogs based on geometric means.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Against an existing infestation, efficacy of both Simparica Trio\u2122 and NexGard Spectra<jats:sup>\u00ae<\/jats:sup> was 99.6% and 100% at 48 and 72 h time points, respectively (<jats:italic>P\u2009<\/jats:italic>=\u20091.000). Against subsequent weekly infestations, treatment with Simparica Trio\u2122 and NexGard Spectra<jats:sup>\u00ae<\/jats:sup> resulted in efficacy of\u2009\u2265\u200997.7% and\u2009\u2265\u200995.5% (<jats:italic>P<\/jats:italic>\u2009\u2265\u20090.0911), respectively at the 48 h time point and at the 72 h time point, Simparica Trio\u2122 and NexGard Spectra<jats:sup>\u00ae<\/jats:sup> resulted in efficacy of\u2009\u2265\u200999.0% and\u2009\u2265\u200998.4% (<jats:italic>P<\/jats:italic>\u2009\u2265\u20090.0511), respectively. There were no treatment-related adverse events in the study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Single doses of Simparica Trio\u2122 and NexGard Spectra<jats:sup>\u00ae<\/jats:sup> were highly efficacious and provided comparable efficacy against the Australian paralysis tick, <jats:italic>I. holocyclus<\/jats:italic> for up to 35 days.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13071-020-04323-8","type":"journal-article","created":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T06:02:53Z","timestamp":1599285773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy of combination products containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) or afoxolaner and milbemycin (NexGard Spectra\u00ae) against induced infestations of Ixodes holocyclus in dogs"],"prefix":"10.1186","volume":"13","author":[{"given":"Raj","family":"Packianathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Bruellke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrissie","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Maeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,5]]},"reference":[{"key":"4323_CR1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1051\/parasite\/2016026","volume":"23","author":"F Beugnet","year":"2016","unstructured":"Beugnet F, de Vos C, Liebenberg J, Halos L, Larsen D, Fourie J. Efficacy of afoxolaner in a clinical field study in dogs naturally infested with Sarcoptes scabiei. Parasite. 2016;23:26.","journal-title":"Parasite."},{"key":"4323_CR2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.vetpar.2016.02.017","volume":"222","author":"C Becskei","year":"2016","unstructured":"Becskei C, De Bock F, Illambas J, Cherni JA, Fourie JJ, Lane M, et al. Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica\u2122), for the treatment of sarcoptic mange in dogs. Vet Parasitol. 2016;222:56\u201361.","journal-title":"Vet Parasitol."},{"key":"4323_CR3","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1186\/s13071-018-3083-2","volume":"11","author":"W Lebon","year":"2018","unstructured":"Lebon W, Beccati M, Bourdeau P, Brement T, Bruet V, Cekiera A, et al. Efficacy of two formulations of afoxolaner (NexGard\u00ae and NexGard Spectra\u00ae) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe. Parasit Vectors. 2018;11:506.","journal-title":"Parasit Vectors."},{"key":"4323_CR4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.vetpar.2016.02.027","volume":"222","author":"RH Six","year":"2016","unstructured":"Six RH, Becskei C, Mazaleski MM, Fourie JJ, Mahabir SP, Myers MR, et al. Efficacy of sarolaner, a novel oral isoxazoline, against two common mite infestations in dogs: Demodex spp and Otodectes cynotis. Vet Parasitol. 2016;222:62\u20136.","journal-title":"Vet Parasitol."},{"key":"4323_CR5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s13071-016-1670-7","volume":"9","author":"J Taenzler","year":"2016","unstructured":"Taenzler J, Liebenberg J, Roepke RKA, Fr\u00e9nais R, Heckeroth AR. Efficacy of fluralaner administered either orally or topically for the treatment of naturally acquired Sarcoptes scabiei var canis infestation in dogs. Parasit Vectors. 2016;9:392.","journal-title":"Parasit Vectors."},{"key":"4323_CR6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.vetpar.2016.02.019","volume":"222","author":"TL McTier","year":"2016","unstructured":"McTier TL, Chubb N, Curtis MP, Hedges L, Inskeep GA, Knauer CS, et al. Discovery of sarolaner: A novel, orally administered, broad-spectrum, isoxazoline ectoparasiticide for dogs. Vet Parasitol. 2016;222:3\u201311.","journal-title":"Vet Parasitol."},{"key":"4323_CR7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.vetpar.2014.02.020","volume":"201","author":"WL Shoop","year":"2014","unstructured":"Shoop WL, Hartline EJ, Gould BR, Waddell ME, Mcdowell RG, Kinney JB, et al. Discovery and mode of action of afoxolaner, a new isoxazoline parasiticide for dogs. Vet Parasitol. 2014;201:179\u201389.","journal-title":"Vet Parasitol."},{"key":"4323_CR8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ibmb.2013.11.009","volume":"45","author":"M Gassel","year":"2014","unstructured":"Gassel M, Wolf C, Noack S, Williams H, Ilg T. The novel isoxazoline ectoparasiticide fluralaner: Selective inhibition of arthropod \u03b3-aminobutyric acid- and L-glutamate-gated chloride channels and insecticidal\/acaricidal activity. Insect Biochem Mol Biol. 2014;45:111\u201324.","journal-title":"Insect Biochem Mol Biol."},{"key":"4323_CR9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1186\/s13071-017-2477-x","volume":"10","author":"D Cavalleri","year":"2017","unstructured":"Cavalleri D, Murphy M, Gorbea RL, Seewald W, Drake J. Laboratory evaluations of the immediate and sustained effectiveness of lotilaner (Credelio\u2122) against three common species of ticks affecting dogs in Europe. Parasit Vectors. 2017;10:527.","journal-title":"Parasit Vectors."},{"key":"4323_CR10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1186\/s13071-019-3702-6","volume":"12","author":"K Kryda","year":"2019","unstructured":"Kryda K, Six RH, Walsh KF, Holzmer SJ, Chapin S, Mahabir SP, et al. Laboratory and field studies to investigate the efficacy of a novel, orally administered combination product containing moxidectin, sarolaner and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs. Parasit Vectors. 2019;12:445.","journal-title":"Parasit Vectors."},{"key":"4323_CR11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13071-020-3947-0","volume":"13","author":"C Becskei","year":"2020","unstructured":"Becskei C, Kryda K, Fias D, Follis SL, Wozniakiewicz M, Mahabir SP, et al. Field efficacy and safety of a novel oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) against naturally acquired gastrointestinal nematode infections in dogs presented as veterinary patients in Europe and the USA. Parasit Vectors. 2020;13:70.","journal-title":"Parasit Vectors."},{"key":"4323_CR12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13071-020-3950-5","volume":"13","author":"C Becskei","year":"2020","unstructured":"Becskei C, Kryda K, Thys M, Holzmer S, Bowersock L, Fernandes T, et al. Efficacy of a new oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) against induced ascarid infections in dogs. Parasit Vectors. 2020;13:71.","journal-title":"Parasit Vectors."},{"key":"4323_CR13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13071-020-3951-4","volume":"13","author":"C Becskei","year":"2020","unstructured":"Becskei C, Thys M, Kryda K, Meyer L, Martorell S, Geurden T, et al. Efficacy of Simparica Trio\u2122, a novel chewable tablet containing sarolaner, moxidectin and pyrantel, against induced hookworm infections in dogs. Parasit Vectors. 2020;13:99.","journal-title":"Parasit Vectors."},{"key":"4323_CR14","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s13071-019-3685-3","volume":"12","author":"TL McTier","year":"2019","unstructured":"McTier TL, Six RH, Pullins A, Chapin S, Kryda K, Mahabir SP, et al. Preventive efficacy of oral moxidectin at various doses and dosage regimens against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs. Parasit Vectors. 2019;12:444.","journal-title":"Parasit Vectors."},{"key":"4323_CR15","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1751-0813.2003.tb12546.x","volume":"81","author":"B Brown","year":"2003","unstructured":"Brown B, Copeman D. Zoonotic importance of parasites in wild dogs caught in the vicinity of Townsville. Aust Vet J. 2003;81:700\u20132.","journal-title":"Aust Vet J."},{"key":"4323_CR16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1751-0813.1969.tb07890.x","volume":"45","author":"CH Carlisle","year":"1969","unstructured":"Carlisle CH. The incidence of Dirofilaria immitis (heartworm) in dogs in Queensland. Aust Vet J. 1969;45:535\u20138.","journal-title":"Aust Vet J."},{"key":"4323_CR17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1751-0813.1970.tb01997.x","volume":"46","author":"CH Carlisle","year":"1970","unstructured":"Carlisle CH. Observations on the treatment of Dirofilaria immitis infection in dogs in Brisbane. Aust Vet J. 1970;46:185\u20139.","journal-title":"Aust Vet J."},{"key":"4323_CR18","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1751-0813.1984.tb07155.x","volume":"61","author":"C Carlisle","year":"1984","unstructured":"Carlisle C, Atwell R. A survey of heartworm in dogs in Australia. Aust Vet J. 1984;61:356\u201360.","journal-title":"Aust Vet J."},{"key":"4323_CR19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1186\/s13071-016-1821-x","volume":"9","author":"C Nguyen","year":"2016","unstructured":"Nguyen C, Koh WL, Casteriano A, Beijerink N, Godfrey C, Brown G, et al. Mosquito-borne heartworm Dirofilaria immitis in dogs from Australia. Parasit Vectors. 2016;9:535.","journal-title":"Parasit Vectors."},{"key":"4323_CR20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.vetpar.2015.10.020","volume":"215","author":"FA Smout","year":"2016","unstructured":"Smout FA, Skerratt LF, Butler JR, Johnson CN, Congdon BC. Dingoes (Canis dingo Meyer, 1793) continue to be an important reservoir host of Dirofilaria immitis in low density housing areas in Australia. Vet Parasitol. 2016;215:6\u201310.","journal-title":"Vet Parasitol."},{"key":"4323_CR21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s13071-016-1675-2","volume":"9","author":"DB Meyer Steiger","year":"2016","unstructured":"Meyer Steiger DB, Ritchie SA, Laurance SGW. Mosquito communities and disease risk influenced by land use change and seasonality in the Australian tropics. Parasit Vectors. 2016;9:387.","journal-title":"Parasit Vectors."},{"key":"4323_CR22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0304-4017(84)90048-7","volume":"16","author":"JD Dunsmore","year":"1984","unstructured":"Dunsmore JD, Thompson RCA, Bates IA. Prevalence and survival of Toxocara canis eggs in the urban environment of Perth. Australia. Vet Parasitol. 1984;16:303\u201311.","journal-title":"Australia. Vet Parasitol."},{"key":"4323_CR23","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/bs.apar.2020.01.033","volume":"109","author":"DJ Jenkins","year":"2020","unstructured":"Jenkins DJ. Toxocara canis in Australia. Adv Parasitol. 2020;109:873\u20138.","journal-title":"Adv Parasitol."},{"key":"4323_CR24","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/avj.12218","volume":"92","author":"DJ Jenkins","year":"2014","unstructured":"Jenkins DJ, Lievaart JJ, Boufana B, Lett WS, Bradshaw H, Armua-Fernandez MT. Echinococcus granulosus and other intestinal helminths: current status of prevalence and management in rural dogs of eastern Australia. Aust Vet J. 2014;92:292\u20138.","journal-title":"Aust Vet J."},{"key":"4323_CR25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1751-0813.1988.tb07376.x","volume":"65","author":"P Morrison","year":"1988","unstructured":"Morrison P, Stanton R, Pilatti E. Echinococcus granulosus infection in wild dogs in south-eastern New South Wales. Aust Vet J. 1988;65:97\u20138.","journal-title":"Aust Vet J."},{"key":"4323_CR26","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.vetpar.2013.04.011","volume":"196","author":"KR Eppleston","year":"2013","unstructured":"Eppleston KR, Kelman M, Ward MP. Distribution, seasonality and risk factors for tick paralysis in Australian dogs and cats. Vet Parasitol. 2013;196:460\u20138.","journal-title":"Vet Parasitol."},{"key":"4323_CR27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13071-016-1480-y","volume":"9","author":"TL Greay","year":"2016","unstructured":"Greay TL, Oskam CL, Gofton AW, Rees RL, Ryan UM, Irwin PJ. A survey of ticks (Acari: Ixodidae) of companion animals in Australia. Parasit Vectors. 2016;9:207.","journal-title":"Parasit Vectors."},{"key":"4323_CR28","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1751-0813.2007.00183.x","volume":"85","author":"J Jackson","year":"2007","unstructured":"Jackson J, Beveridge I, Chilton NB, Andrews RH. Distributions of the paralysis ticks Ixodes cornuatus and Ixodes holocyclus in south-eastern Australia. Aust Vet J. 2007;85:420\u20134.","journal-title":"Aust Vet J."},{"key":"4323_CR29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/avj.12883","volume":"98","author":"D Barker","year":"2020","unstructured":"Barker D, Barker SC. Survey of cases of tick-paralysis and the presence of the eastern paralysis tick, Ixodes holocyclus, and the southern paralysis tick, Ixodes cornuatus, in the Greater Melbourne Area. Aust Vet J. 2020;98:2\u201310.","journal-title":"Aust Vet J."},{"key":"4323_CR30","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ijpara.2014.08.008","volume":"44","author":"SC Barker","year":"2014","unstructured":"Barker SC, Walker AR, Campelo D. A list of the 70 species of Australian ticks; diagnostic guides to and species accounts of Ixodes holocyclus (paralysis tick), Ixodes cornuatus (southern paralysis tick) and Rhipicephalus australis (Australian cattle tick); and consideration of the place of Australia in the evolution of ticks with comments on four controversial ideas. Int J Parasitol. 2014;44:941\u201353.","journal-title":"Int J Parasitol."},{"key":"4323_CR31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/avj.12130","volume":"91","author":"MN Westwood","year":"2013","unstructured":"Westwood MN, Emery DL, Dhand NK. Clinical presentation and treatment of tick paralysis in dogs and cats in Sydney (2001\u20132010). Aust Vet J. 2013;91:491\u20138.","journal-title":"Aust Vet J."},{"key":"4323_CR32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1751-0813.2008.00346.x","volume":"86","author":"CT Holland","year":"2008","unstructured":"Holland CT. Asymmetrical focal neurological deficits in dogs and cats with naturally occurring tick paralysis (Ixodes holocyclus): 27 cases (1999\u20132006). Aust Vet J. 2008;86:377\u201384.","journal-title":"Aust Vet J."},{"key":"4323_CR33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/avj.12061","volume":"91","author":"RA Webster","year":"2013","unstructured":"Webster RA, Mills PC, Morton JM. Indications, durations and outcomes of mechanical ventilation in dogs and cats with tick paralysis caused by Ixodes holocyclus: 61 cases (2008\u20132011). Aust Vet J. 2013;91:233\u20139.","journal-title":"Aust Vet J."},{"key":"4323_CR34","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1751-0813.2001.tb12986.x","volume":"79","author":"RB Atwell","year":"2001","unstructured":"Atwell RB, Campbell FE, Evans EA. Prospective survey of tick paralysis in dogs. Aust Vet J. 2001;79:412\u20138.","journal-title":"Aust Vet J."},{"key":"4323_CR35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/avj.12891","volume":"98","author":"AM Padula","year":"2020","unstructured":"Padula AM, Leister EM, Webster RA. Tick paralysis in dogs and cats in Australia: treatment and prevention deliverables from 100 years of research. Aust Vet J. 2020;98:53\u20139.","journal-title":"Aust Vet J."},{"key":"4323_CR36","first-page":"30","volume":"5571","author":"M Awad","year":"2016","unstructured":"Awad M. The decline in tick paralysis cases. Centre for Veterinary Education Control & Therapy Series. 2016;5571:30\u20131.","journal-title":"Centre for Veterinary Education Control & Therapy Series."},{"key":"4323_CR37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0001-706X(96)00016-2","volume":"62","author":"P Prociv","year":"1996","unstructured":"Prociv P, Croese J. Human enteric infection with Ancylostoma caninum: hookworms reappraised in the light of a \u201cnew\u201d zoonosis. Acta Trop. 1996;62:23\u201344.","journal-title":"Acta Trop."},{"key":"4323_CR38","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pt.2010.01.005","volume":"26","author":"DD Bowman","year":"2010","unstructured":"Bowman DD, Montgomery SP, Zajac AM, Eberhard ML, Kazacos KR. Hookworms of dogs and cats as agents of cutaneous larva migrans. Trends Parasitol. 2010;26:162\u20137.","journal-title":"Trends Parasitol."},{"key":"4323_CR39","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.ijpara.2013.07.004","volume":"43","author":"CN Macpherson","year":"2013","unstructured":"Macpherson CN. The epidemiology and public health importance of toxocariasis: a zoonosis of global importance. Int J Parasitol. 2013;43:999\u20131008.","journal-title":"Int J Parasitol."},{"key":"4323_CR40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5694\/j.1326-5377.1996.tb94103.x","volume":"164","author":"DJ Jenkins","year":"1996","unstructured":"Jenkins DJ, Power K. Human hydatidosis in New South Wales and the Australian Capital Territory, 1987\u20131992. Med J Aust. 1996;164:18\u201321.","journal-title":"Med J Aust."},{"key":"4323_CR41","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1093\/brain\/120.11.1975","volume":"120","author":"PJ Grattan-Smith","year":"1997","unstructured":"Grattan-Smith PJ, Morris JG, Johnston HM, Yiannikas C, Malik R, Russell R, et al. Clinical and neurophysiological features of tick paralysis. Brain. 1997;120:1975\u201387.","journal-title":"Brain."},{"key":"4323_CR42","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1128\/CMR.00012-12","volume":"25","author":"F Sim\u00f3n","year":"2012","unstructured":"Sim\u00f3n F, Siles-Lucas M, Morch\u00f3n R, Gonz\u00e1lez-Miguel J, Mellado I, Carret\u00f3n E, et al. Human and animal dirofilariasis: the emergence of a zoonotic mosaic. Clin Microbiol Rev. 2012;25:507\u201344.","journal-title":"Clin Microbiol Rev."},{"key":"4323_CR43","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/jtm.12174","volume":"22","author":"JH Diaz","year":"2014","unstructured":"Diaz JH. Increasing risks of human dirofilariasis in travelers. J Travel Med. 2014;22:116\u201323.","journal-title":"J Travel Med."},{"key":"4323_CR44","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/jisesa\/ieu133","volume":"14","author":"P Mayne","year":"2014","unstructured":"Mayne P, Song S, Shao R, Burke J, Wang Y, Roberts T. Evidence for Ixodes holocyclus (Acarina: Ixodidae) as a vector for human lyme borreliosis infection in Australia. J Insect Sci. 2014;14:271.","journal-title":"J Insect Sci."},{"key":"4323_CR45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1196\/annals.1374.008","volume":"1078","author":"S Graves","year":"2006","unstructured":"Graves S, Unsworth N, Stenos J. Rickettsioses in Australia. Ann N Y Acad Sci. 2006;1078:74\u20139.","journal-title":"Ann N Y Acad Sci."},{"key":"4323_CR46","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/tropicalmed1010004","volume":"1","author":"S Graves","year":"2016","unstructured":"Graves S, Jackson C, Hussain-Yusuf H, Vincent G, Nguyen C, Stenos J, et al. Ixodes holocyclus tick-transmitted human pathogens in north-eastern New South Wales. Australia. Trop Med Infect Dis. 2016;1:4.","journal-title":"Australia. Trop Med Infect Dis."},{"key":"4323_CR47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1155\/2010\/420628","volume":"21","author":"DN Fisman","year":"2010","unstructured":"Fisman DN, Laupland KB. The \u201bOne Health\u02bc paradigm: time for infectious diseases clinicians to take note? Can J Infect Dis Med Microbiol. 2010;21:111\u20134.","journal-title":"Can J Infect Dis Med Microbiol."},{"key":"4323_CR48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fvets.2018.00014","volume":"5","author":"D Destoumieux-Garz\u00f3n","year":"2018","unstructured":"Destoumieux-Garz\u00f3n D, Mavingui P, Boetsch G, Boissier J, Darriet F, Duboz P, et al. The one health concept: 10 years old and a long road ahead. Front Vet Sci. 2018;5:14.","journal-title":"Front Vet Sci."},{"key":"4323_CR49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13071-017-2024-9","volume":"10","author":"R Packianathan","year":"2017","unstructured":"Packianathan R, Hodge A, Bruellke N, Davis K, Maeder S. Comparative speed of kill of sarolaner (Simparica\u00ae) and afoxolaner (NexGard\u00ae) against induced infestations of Ixodes holocyclus on dogs. Parasit Vectors. 2017;10:98.","journal-title":"Parasit Vectors."},{"key":"4323_CR50","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13071-020-3946-1","volume":"13","author":"C Becskei","year":"2020","unstructured":"Becskei C, Fias D, Mahabir SP, Farkas R. Efficacy of a novel oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) against natural flea and tick infestations on dogs presented as veterinary patients in Europe. Parasit Vectors. 2020;13:72.","journal-title":"Parasit Vectors."},{"key":"4323_CR51","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13071-020-3949-y","volume":"13","author":"C Becskei","year":"2020","unstructured":"Becskei C, Liebenberg J, Thys M, Mahabir SP. Efficacy of a novel chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) against four common tick species infesting dogs in Europe. Parasit Vectors. 2020;13:100.","journal-title":"Parasit Vectors."},{"key":"4323_CR52","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13071-020-3944-3","volume":"13","author":"K Kryda","year":"2020","unstructured":"Kryda K, Mahabir SP, Carter L, Everett WR, Young DR, Meyer L, et al. Laboratory studies evaluating the efficacy of a novel orally administered combination product containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) for the treatment and control of flea infestations on dogs. Parasit Vectors. 2020;13:57.","journal-title":"Parasit Vectors."},{"key":"4323_CR53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13071-020-3945-2","volume":"13","author":"K Kryda","year":"2020","unstructured":"Kryda K, Mahabir SP, Chapin S, Holzmer SJ, Bowersock L, Everett WR, et al. Efficacy of a novel orally administered combination product containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) against induced infestations of five common tick species infesting dogs in the USA. Parasit Vectors. 2020;13:77.","journal-title":"Parasit Vectors."},{"key":"4323_CR54","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13071-020-3952-3","volume":"13","author":"K Kryda","year":"2020","unstructured":"Kryda K, Mahabir SP, Inskeep T, Rugg J. Safety and efficacy of a novel oral chewable combination tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) against natural flea infestations in client-owned dogs in the USA. Parasit Vectors. 2020;13:98.","journal-title":"Parasit Vectors."},{"key":"4323_CR55","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.vetpar.2013.02.003","volume":"194","author":"AA Marchiondo","year":"2013","unstructured":"Marchiondo AA, Holdsworth PA, Fourie LJ, Rugg D, Kellmann K, Snyder DE. World Association for the Advancement of Veterinary Parasitology (WAAVP) second edition: guidelines for evaluating the efficacy of parasiticides for the treatment, prevention and control of flea and tick infestations on dogs and cats. Vet Parasitol. 2013;194:84\u201397.","journal-title":"Vet Parasitol."},{"key":"4323_CR56","unstructured":"EMEA. Guideline on good clinical practices. VICH Topic GL9 2001. https:\/\/vichsec.org\/en\/guidelines\/pharmaceuticals\/pharma-efficacy\/good-clinical-practice.html. Accessed 23 May 2020."},{"key":"4323_CR57","unstructured":"Australian Pesticides and Veterinary Medicines Authority (APVMA). The WAAVP guideline for fleas and ticks on dogs and cats. https:\/\/apvmagovau\/node\/1040. 2019."},{"key":"4323_CR58","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13071-015-0864-8","volume":"8","author":"P Fisara","year":"2015","unstructured":"Fisara P, Webster M. A randomized controlled trial of the efficacy of orally administered fluralaner (Bravecto) against induced Ixodes holocyclus (Australian paralysis tick) infestations on dogs. Parasit Vectors. 2015;8:257.","journal-title":"Parasit Vectors."},{"key":"4323_CR59","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1751-0813.1987.tb09662.x","volume":"64","author":"JE Ilkiw","year":"1987","unstructured":"Ilkiw JE, Turner DM, Howlett CR. Infestation in the dog by the paralysis tick Ixodes holocyclus. 1. Clinical and histological findings. Aust Vet J. 1987;64:137\u20139.","journal-title":"Aust Vet J."},{"key":"4323_CR60","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1751-0813.1934.tb07833.x","volume":"10","author":"IC Ross","year":"1934","unstructured":"Ross IC. Tick paralysis in the dog. Aust Vet J. 1934;10:182\u20133.","journal-title":"Aust Vet J."},{"key":"4323_CR61","first-page":"310","volume":"4","author":"IC Ross","year":"1927","unstructured":"Ross IC. An experimental study of tick paralysis in Australia. Aust Vet J. 1927;4:310\u201329.","journal-title":"Aust Vet J."}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-020-04323-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-020-04323-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-020-04323-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T23:30:01Z","timestamp":1630798201000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-020-04323-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,5]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4323"],"URL":"https:\/\/doi.org\/10.1186\/s13071-020-04323-8","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,5]]},"assertion":[{"value":"3 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An animal ethics approval was obtained from the Wongaburra Research Centre Animal Ethics Committee on 26 February 2018 prior to the commencement of the study. The animal ethics approval number was ZOE C 17145 W. This study did not report on any data related to humans. All dogs enrolled in the study were owned by the Invetus who conducted this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RP, AH, NB and SM are current employees of Zoetis. CJ was a contracted study investigator.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"448"}}